Maradit-Kremers H, Nicola P J, Crowson C S, Ballman K V, Jacobsen S J, Roger V L, Gabriel S E
Department of Health Sciences Research, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.
Ann Rheum Dis. 2007 Jan;66(1):76-80. doi: 10.1136/ard.2006.053710. Epub 2006 Jul 3.
Inflammatory markers are associated with heart failure. Patients with rheumatoid arthritis have twice the risk of heart failure compared with people without rheumatoid arthritis.
To assess whether heart failure in patients with rheumatoid arthritis is preceded by an inflammatory activation as shown by erythrocyte sedimentation rate (ESR), a systemic marker of inflammation.
A population-based inception cohort of 575 patients with rheumatoid arthritis, free of heart failure at their rheumatoid arthritis incidence date, was followed up longitudinally until death or 2001. During 15 years of follow-up, they had a median of 15 ESR tests, and 172 patients had new-onset heart failure (Framingham Heart Study criteria). The follow-up period, beginning with the rheumatoid arthritis incidence date and ending with date of the last follow-up, was divided into 6-month intervals. The proportions of patients with at least one ESR value >/=40 mm/h and with anaemia (haemoglobin <11 g/dl) within each 6-month interval were plotted against time from fulfilment of heart failure criteria. A binomial test was used to compare proportions.
In patients with rheumatoid arthritis who developed heart failure, the proportion with ESR >/=40 mm/h was highest (23%) during the 6-month period immediately preceding the new-onset heart failure, as compared with the average ESR during the entire remaining follow-up period, both before and after heart failure (10.6%; p<0.01). The proportion of patients with anaemia peaked (54%) during the 6-month period after heart failure.
Inflammatory stimuli may be involved in the initiation of heart failure among patients with rheumatoid arthritis.
炎症标志物与心力衰竭相关。类风湿关节炎患者发生心力衰竭的风险是无类风湿关节炎者的两倍。
评估类风湿关节炎患者发生心力衰竭之前是否存在如红细胞沉降率(ESR)所示的炎症激活,ESR是一种全身性炎症标志物。
对575例类风湿关节炎患者组成的基于人群的起始队列进行纵向随访,直至死亡或2001年,这些患者在类风湿关节炎发病时无心力衰竭。在15年的随访期间,他们平均进行了15次ESR检测,172例患者发生了新发心力衰竭(符合弗雷明汉心脏研究标准)。随访期从类风湿关节炎发病日期开始至最后一次随访日期结束,分为6个月的间隔期。将每个6个月间隔期内至少有一次ESR值≥40 mm/h以及贫血(血红蛋白<11 g/dl)的患者比例与达到心力衰竭标准后的时间作图。采用二项检验比较比例。
在发生心力衰竭的类风湿关节炎患者中,新发心力衰竭前6个月期间ESR≥40 mm/h的患者比例最高(23%),与心力衰竭前后整个剩余随访期的平均ESR(10.6%)相比,差异有统计学意义(p<0.01)。贫血患者比例在心力衰竭后6个月期间达到峰值(54%)。
炎症刺激可能参与类风湿关节炎患者心力衰竭的起始过程。